Found: 246
Select item for more details and to access through your institution.
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND Study.
- Published in:
- CNS Drugs, 2024, v. 38, n. 12, p. 1017, doi. 10.1007/s40263-024-01118-8
- By:
- Publication type:
- Article
New Thoughts on Sinus Headache.
- Published in:
- Allergy & Asthma Proceedings, 2004, v. 25, n. 2, p. 95
- By:
- Publication type:
- Article
Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study.
- Published in:
- Cephalalgia Reports, 2021, v. 4, p. 1, doi. 10.1177/25158163211040061
- By:
- Publication type:
- Article
CGRP and headache: a brief review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
New treatments for headache.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-09071-6
- By:
- Publication type:
- Article
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcome for headache and pain-free nonresponders to treatment of the first attack: A pooled post-hoc analysis of four randomized trials of eletriptan 40 mg.
- Published in:
- Cephalalgia, 2014, v. 34, n. 5, p. 376, doi. 10.1177/0333102413512035
- By:
- Publication type:
- Article
Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study.
- Published in:
- Cephalalgia, 2014, v. 34, n. 2, p. 126, doi. 10.1177/0333102413500726
- By:
- Publication type:
- Article
Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1433423
- By:
- Publication type:
- Article
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1291102
- By:
- Publication type:
- Article
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 1785, doi. 10.2147/PPA.S170636
- By:
- Publication type:
- Article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura.
- Published in:
- Journal of Pain Research, 2021, v. 14, p. 2529, doi. 10.2147/JPR.S322292
- By:
- Publication type:
- Article
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial.
- Published in:
- Journal of Pain Research, 2021, v. 14, p. 549, doi. 10.2147/JPR.S287571
- By:
- Publication type:
- Article
Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and Disability.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 1, p. 246, doi. 10.3390/ijerph18010246
- By:
- Publication type:
- Article
Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients.
- Published in:
- Brain Sciences (2076-3425), 2016, v. 6, n. 3, p. 30, doi. 10.3390/brainsci6030030
- By:
- Publication type:
- Article
Acute Treatment of Migraines.
- Published in:
- CNS Drugs, 2012, v. 26, n. 10, p. 823, doi. 10.2165/11635440-000000000-00000
- By:
- Publication type:
- Article
Role of Melatonin in the Pathophysiology of Migraine: Implications for Treatment.
- Published in:
- CNS Drugs, 2006, v. 20, n. 5, p. 343, doi. 10.2165/00023210-200620050-00001
- By:
- Publication type:
- Article
Commentary on 2022 guidelines on clinical trial design in cluster headache and further suggestions.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01732-3
- By:
- Publication type:
- Article
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01688-w
- By:
- Publication type:
- Article
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01587-0
- By:
- Publication type:
- Article
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01519-4
- By:
- Publication type:
- Article
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 2, p. 159, doi. 10.1001/jamaneurol.2021.4678
- By:
- Publication type:
- Article
Pharmacologic Management of Migraine.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Migraine – the forgotten epidemic: development of the EHF/WHA Rome Declaration on Migraine.
- Published in:
- Journal of Headache & Pain, 2006, v. 7, n. 6, p. 433, doi. 10.1007/s10194-006-0349-4
- By:
- Publication type:
- Article
Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine.
- Published in:
- Journal of Headache & Pain, 2005, v. 6, n. 3, p. 112, doi. 10.1007/s10194-005-0164-3
- By:
- Publication type:
- Article
Treatment of Headache Pain with Botulinum Neurotoxins.
- Published in:
- Pain Practice, 2004, v. 4, p. S38, doi. 10.1111/j.1533-2500.2004.04013.x
- By:
- Publication type:
- Article
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 14, p. 1450, doi. 10.1177/03331024221120266
- By:
- Publication type:
- Article
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 6, doi. 10.1177/0333102420973994
- By:
- Publication type:
- Article
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 3, p. 263, doi. 10.1007/s40261-021-01115-5
- By:
- Publication type:
- Article
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 859, doi. 10.1111/head.14775
- By:
- Publication type:
- Article
Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 4, p. 333, doi. 10.1111/head.14692
- By:
- Publication type:
- Article
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1423, doi. 10.1111/head.14612
- By:
- Publication type:
- Article
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 10, p. 1380, doi. 10.1111/head.14494
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 730, doi. 10.1111/head.14536
- By:
- Publication type:
- Article
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 377, doi. 10.1111/head.14469
- By:
- Publication type:
- Article
Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 1, p. 79, doi. 10.1111/head.14439
- By:
- Publication type:
- Article
Migraine treatment with external concurrent occipital and trigeminal neurostimulation—A randomized controlled trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 8, p. 989, doi. 10.1111/head.14350
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 5, p. 624, doi. 10.1111/head.14313
- By:
- Publication type:
- Article
Network meta‐analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 482, doi. 10.1111/head.14283
- By:
- Publication type:
- Article
Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 420, doi. 10.1111/head.14266
- By:
- Publication type:
- Article
Effects of acute and preventive therapies for episodic and chronic cluster headache: A scoping review of the literature.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 3, p. 329, doi. 10.1111/head.14284
- By:
- Publication type:
- Article
Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1411, doi. 10.1111/head.14208
- By:
- Publication type:
- Article